ArticleFrontiers in medicine2023

An open-label randomized controlled trial of leflunomide in patients with acute SARS-CoV-2 omicron variant infection.

Zhou Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.